When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Merkel cell carcinoma

Última revisão: 13 Sep 2025
Última atualização: 20 Sep 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • firm, nontender, red or pink-to-violaceous or skin-colored papule or subcutaneous nodule
  • rapidly growing lesion
Detalhes completos

Outros fatores diagnósticos

  • enlarged lymph nodes
  • ulceration or bleeding cutaneous lesion
  • small papules or nodules surrounding a primary lesion
Detalhes completos

Fatores de risco

  • cumulative ultraviolet (UV) exposure
  • immunosuppression
  • advancing age
  • male sex
  • white skin
  • Merkel cell polyomavirus (MCPyV) infection with oncogenic transformation
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • biopsy and histopathologic assessment
  • dermoscopy
Detalhes completos

Investigações a serem consideradas

  • lymph node ultrasound
  • whole-body PET scan
  • CT scan with contrast chest/abdomen/pelvis (± neck)
  • brain MRI
  • fine-needle aspiration or core biopsy
  • sentinel lymph node biopsy (SLNB)
  • Merkel cell polyomavirus serology
Detalhes completos

Novos exames

  • circulating tumor DNA (ctDNA) analysis

Algoritmo de tratamento

AGUDA

localized disease: stage I or II (T-any cN0 M0)

regional disease: stage IIIA

regional disease: unknown primary tumor with clinically apparent nodal disease

regional disease: stage IIIB

distant metastatic disease: stage IV

Colaboradores

Autores

Kelly Harms, MD, PhD

Associate Professor of Dermatology

Michigan Medicine

University of Michigan

Ann Arbor

MI

Declarações

KH is a panel member for NCCN guidelines on Merkel cell carcinoma. She serves as Chair of Professionalism and Ethics for the Michigan Dermatological Society Board of Directors. KH is married to Paul Harms, a co-author of research on Merkel cell carcinoma.

Alison Lee, MD, MHS

Clinical Fellow

Department of Dermatology

Michigan Medicine

University of Michigan

Ann Arbor

MI

Declarações

AL declares that she has no competing interests.

Revisores

Isaac Brownell, MD, PhD

Senior Investigator

Dermatology Branch

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institutes of Health (NIH)

Bethesda

MD

Declarações

IB declares that he has no competing interests.

Zoe Venables, MbChB, MMedSci, MRCP

Clinical Associate Professor and Consultant Dermatologist

Norfolk and Norwich University Hospitals NHS Foundation Trust

Norwich

UK

Declarações

ZV declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Merkel cell carcinoma [internet publication].Texto completo

Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). ​Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.Texto completo  Resumo

Lugowska I, Becker JC, Ascierto PA, et al; ESMO Guidelines Committee. Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2024 May;9(5):102977.Texto completo  Resumo

Silk AW, Barker CA, Bhatia S, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. J Immunother Cancer. 2022 Jul;10(7):e004434.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Merkel cell carcinoma images
  • Diagnósticos diferenciais

    • Basal cell carcinoma (BCC)
    • Squamous cell carcinoma (SCC) of the skin
    • Amelanotic/hypomelanotic melanoma
    Mais Diagnósticos diferenciais
  • Diretrizes

    • NCCN clinical practice guidelines in oncology: Merkel cell carcinoma
    • Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal